Skip to main content
. 2016 Feb 2;31(4):586–594. doi: 10.1093/ndt/gfv457

Table 4.

Outcomes stratified by Day3-AKI

Category Overall No AKI AKI P-value (no AKI versus AKI)
Demographics n (%) 156 141 (90.4) 15 (9.6)
Male (%) 98 (52.7) 71 (50.4) 11 (73.3) ns
Age (years) 8.4 (2.7, 15.5) 8.2 (2.7, 15.1) 12.8 (2.9, 18.0) ns
Day0 PRISM-III 8 (3, 14) 7 (3, 13) 15 (11, 23) <0.001
Day0 renal angina 52 (33.3) 40 (28.4) 12 (80) χ 2 = 16.2, P < 0.001
Sepsis Dx (%) 41 (26.3) 31 (21.9) 10 (66.7) χ 2 = 13.9, P < 0.001
Transplant history (%) 20 (12.8) 13 (9.2) 7 (46.7) χ 2 = 17.1, P < 0.001
Outcomes Mechanical Vent days 2 (0, 7) 2 (0, 6) 6 (3, 15) 0.03
CRRT use (%) 6 (85.7) 0 6 (100) χ 2 = 48.8, P < 0.001
Organ failure days 3 (1, 8) 3 (1, 7) 7 (3, 16) 0.03
Hospital LOS (days) 17 (8, 34) 16 (8, 30) 38 (16, 69) 0.02
ICU LOS (days) 6 (3, 12) 6 (3, 12) 8 (6, 18) 0.02
Mortality (%) 9 (7.1) 6 (4) 3 (20) χ 2 = 7.4, P = 0.007

Patients in AKI-CHERUB remaining in the ICU on Day3 of admission to the PICU dichotomized by the presence or the absence of severe AKI on Day3 of ICU admission. All values are expressed as medians with interquartile ranges except where designated. n, sample size; AKI by SCr-KDIGO 2–3, AKI diagnosed by change in SCr from baseline per the KDIGO Staging Criteria Stages 2–3; Dx, diagnosis; Vent, ventilation; CRRT, continuous renal replacement therapy; LOS, length of stay; ns, not significant.